For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230504:nRSD4032Ya&default-theme=true
RNS Number : 4032Y Solgenics Limited 04 May 2023
News Release
PDMR Dealing
4 May 2023: Solgenics Limited (the "Company") announces it has been notified
that on 3 May 2023, Scott Fletcher, Non-Executive Director, purchased an
aggregate of 19,499,999 ordinary shares of no par value in the Company
("Shares").
Scott Fletcher's purchases were made in compliance with the Company's share
dealing policy, increasing his beneficial interest in Ordinary Shares in the
Company to 142,479,089 Ordinary Shares, representing 25.15 per cent. of the
Company's issued share capital.
Articles of Association
Under Article 32 of the Company's Articles of Association, where a person or
persons acting in concert acquire 30% or more of the Company's issued share
capital, the Board may, but is not obliged to require such persons to extend
the offer to all shareholders.
Further to the announcement on 16 January 2023 in connection with the loan
conversion, whilst the Directors do not believe Hanno Pengilly, Seritza
Limited, Mike Haworth and Scott Fletcher to be acting in concert, for the
purposes of Article 32, Aman Sachdeva, as the independent director has agreed
that it is in the best interest of the Company following the Company's
announcement of intention to delist, not to restrict any of them from
acquiring further shares given that certain shareholders may wish to sell
their shares ahead of the potential delisting. This will be reassessed in
light of the then current circumstances in the event that any of Seritza
Limited, Mike Haworth or Scott Fletcher (with their connected parties)
individually own or control 30% or more of the issued share capital or if, in
aggregate, they own or control 50% or more of the issued share capital.
Enquiries
For further information please visit www.solgenics.com
(http://www.solgenics.com) or contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Liberum Capital Limited: Scott Mathieson, Edward Thomas, Kane Collings +44 (0) 20 3100 2000
NOMAD & Joint Broker
Novum Securities Limited Colin Rowbury +44 (0) 20 7399 9427
Joint Broker
Elizabeth Johnson +44 (0) 777 56 55 927
Pimlico Advisory Ltd
Investor Relations
This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 which is part of UK law by virtue of
the European Union (Withdrawal) Act 2018. Upon publication of this
Announcement and such information is now considered to be in the public
domain. The person who arranged for the release of this announcement on behalf
of the Company was Hanno Pengilly, CEO.
About Solgenics
Solgenics is an African renewable energy development company focused on the
development of a 300MW solar PV plus BESS renewable energy in the Tete
Province in northern Mozambique (the "Tete Solar Project").
It is the intention that the Tete Solar Project will connect to the Mozambique
grid with target power offtakers in Mozambique and the Southern African Power
Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's leading
sustainable energy resources and is fully aligned with Government's objective
to become a champion for energy transition impacting all Southern Africa.
On 3 May 2023, Solgenics announced that it will shortly be posting a circular
to shareholders (in connection with a proposal for the cancellation of
admission of the ordinary shares of no par value in the Company ("Ordinary
Shares") to trading on AIM (the "Cancellation"), pursuant to Rule 41 of the
AIM Rules for Companies. Accordingly, if the resolution to approve the
cancellation is approved by shareholders, the last day of dealings in the
Ordinary Shares on AIM is expected to be 6 June 2023, and the Cancellation is
expected to become effective at 7.00 a.m. on 7 June 2023.
The notification below is made in accordance with the requirements of the MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Scott Fletcher
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ncondezi Energy Limited
b) LEI 2138003W7PP9STE9J18
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of no par value
Identification code
VGG640631039
b) Nature of the transaction On-market purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) GBP Volume(s)
1. 0.001785 1. 1,000,000
2. 0.0018 2. 8,000,000
3. 0.00183 3. 2,258,947
4. 0.00185 4. 2,000,000
5. 0.001829 5. 2,741,052
6. 0.001826 6. 1,000,000
7. 0.00182 7. 1,500,000
8. 0.001815 8. 1,000,000
d) Aggregated information
- Aggregated volume
- Price 19,499,999
0.00182 GBP
e) Date of the transaction 3 May 2023
f) Place of the transaction London Stock Exchange, AIM
d)
Aggregated information
- Aggregated volume
- Price
19,499,999
0.00182 GBP
e)
Date of the transaction
3 May 2023
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSSMSILEDSEDI